|
Richard W. Krawiec Ph.D. joined us in February 2001 as Vice President Investor Relations and Corporate Communications and became Vice President Corporate Affairs in February 2006. Prior to joining Progenics Dr. Krawiec served as Vice President of Investor Relations and Corporate Communications of Cytogen orporation from 2000 to 2001. Prior to Cytogen Dr. Krawiec headed these departments at La Jolla Pharmaceuticals Inc. during 1999 at Amylin Pharmaceuticals Inc. from 1993 to 1998 and IDEC Pharmaceuticals Inc. previously thereto. Previously Dr. Krawiec was the founder and Editor-In-Chief of Biotechnology Week magazine and the Managing Editor and founder of Biotechnology Newswatch. Dr. Krawiec received a B.S. in Biology from Boston University and a Ph.D. in Biological Sciences from the University of Rhode Island. | 